Befejeződött1. fázis
An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporous magnesium carbonate (DPH001) compared to Nexavar® (sorafenib) in healthy volunteers
Key facts
- Where
- Uppsala, SvédországSee the site
- Phase
- 1. fázis
Where in Svédország
- CTC Clinical Trial Consultants ABUppsala, SvédországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Disruptive Pharma AB
- Trial code
- EU 2024-514496-18-01
- Record updated
- 2025. január 15.